These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19601992)

  • 1. A randomized double-blind pilot study of serum phosphorus normalization in chronic kidney disease: a new paradigm for clinical outcomes studies in nephrology.
    Block GA; Persky MS; Ketteler M; Kestenbaum B; Thadhani R; Kooienga L; Spiegel D; Asplin J; Ehrlich J; Dennis V; Nissenson A; Chertow GM; Wheeler DC
    Hemodial Int; 2009 Jul; 13(3):360-2. PubMed ID: 19601992
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study.
    Spiegel DM; Farmer B; Smits G; Chonchol M
    J Ren Nutr; 2007 Nov; 17(6):416-22. PubMed ID: 17971314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization?
    Tentori F; Hunt WC; Rohrscheib M; Zhu M; Stidley CA; Servilla K; Miskulin D; Meyer KB; Bedrick EJ; Johnson HK; Zager PG
    J Am Soc Nephrol; 2007 Aug; 18(8):2377-84. PubMed ID: 17634440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada.
    Ranganathan N; Friedman EA; Tam P; Rao V; Ranganathan P; Dheer R
    Curr Med Res Opin; 2009 Aug; 25(8):1919-30. PubMed ID: 19558344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to K/DOQI bone metabolism guidelines.
    Smith DH; Johnson ES; Thorp ML; Yang X
    J Ren Nutr; 2009 Jul; 19(4):334-42. PubMed ID: 19539186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intention and outcome in guideline-based nephrological practice: a suitable space for 'clinical technology'.
    Will E
    Nephrol Dial Transplant; 2007 Nov; 22(11):3110-4. PubMed ID: 17720991
    [No Abstract]   [Full Text] [Related]  

  • 9. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes.
    Curtis BM; Ravani P; Malberti F; Kennett F; Taylor PA; Djurdjev O; Levin A
    Nephrol Dial Transplant; 2005 Jan; 20(1):147-54. PubMed ID: 15585514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
    Sigrist MK; Chiarelli G; Lim L; Levin A
    J Ren Care; 2009 Mar; 35 Suppl 1():71-8. PubMed ID: 19222735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: improving outcomes in chronic kidney disease.
    Drüeke T; Foley RN
    Kidney Int Suppl; 2006 Dec; (105):S1-4. PubMed ID: 17136109
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in serum phosphorus, calcium and alkaline phosphatase due to sucralfate.
    Vucelić B; Hadzić N; Gragas J; Puretić Z
    Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):93-6. PubMed ID: 3514490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opinions on the content and effects of clinical practice guidelines for CKD: a survey of nephrologists in Australia and New Zealand.
    Irving MJ; Johnson DW; McDonald S; Walker RG; Frommer MS; Craig JC
    Am J Kidney Dis; 2009 Jun; 53(6):1082-90. PubMed ID: 19394725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized control trial versus retrospective data.
    Lo WK
    Semin Dial; 2007; 20(3):213-6. PubMed ID: 17555486
    [No Abstract]   [Full Text] [Related]  

  • 15. Begin with the end in mind: the value of outcome-driven nephrology social work.
    Callahan MB
    Adv Chronic Kidney Dis; 2007 Oct; 14(4):409-14. PubMed ID: 17904508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in the serum calcium and the serum phosphorus in persons with uremia and in normal persons after administration of sodium phytate- and aluminum hydroxide].
    Friis T; Hahnemann S; Weeke E
    Ugeskr Laeger; 1967 Oct; 129(42):1380-4. PubMed ID: 4870663
    [No Abstract]   [Full Text] [Related]  

  • 17. New developments in anemia management in chronic kidney disease.
    Amerling R; Besarab A; Roy C
    Nephrol News Issues; 2008 Mar; 22(3):suppl 1-8. PubMed ID: 18372676
    [No Abstract]   [Full Text] [Related]  

  • 18. Invasive and innovative nephrology.
    Vachharajani TJ; Atray NK
    Ren Fail; 2005; 27(3):255-8. PubMed ID: 15957540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability study of a personalized and adaptive knowledge-generation telehealthcare system for nephrology (NEFROTEL).
    Prado M; Roa LM; Reina-Tosina J
    Int J Med Inform; 2006 Sep; 75(9):646-57. PubMed ID: 16675297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease: common, harmful and treatable--World Kidney Day 2007.
    Levey AS; Andreoli SP; DuBose T; Provenzano R; Collins AJ
    Am J Nephrol; 2007; 27(1):108-12. PubMed ID: 17308371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.